Epithalon and Skin Research

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Sep 8, 2021

What is Epithalon?

Epithalon, also known as Epitalon, is a four amino acid long peptide that has been suggested by researchers to potentially supplement protein production that has a direct mitigating impact on age-related decline and potentially also in mitigating cancer cell proliferation. Numerous studies on murine models have allowed researchers to hypothesize on the peptide’s possible mechanism of action and breadth of impact. Because of the short size of the Epithalon, researchers consider the possibility that the peptide may enter the cell membrane without the help of transporters and may thereby make its way to the nucleus of cells. This is of utmost importance, as once it is in the nucleus, Epithalon may theoretically effect the regulation of genes, activating some and deactivating others to induce cell-wide downstream changes.

Previous research studies have posited that Epithalon may exhibit the potential to stimulate immune system functioning, which may see a natural arc of decline over time. Investigation of the mechanism of this action uncovered the potential of Epithalon to interact with the promoter region of the interferon-gamma gene. By promoting interferon-gamma production, a key immune regulator, Epithalon may potentially boost T cells’ functioning and support immunity.

The idea that short peptides might affect the DNA-level processes has caused a boom in the scientific community, and research of Epithalon and other short peptides in animal models has seen an uptick in broad research. Such investigations have formulated a theory that Epithalon may possibly impact epidermal aging by activating the cellular repair processes, which often enter the dormant phase with age.

Epithalon Peptide and Skin Aging

Research by scientists in Russia has posited the theory that Epithalon may potentially activate skin fibroblasts, the cells responsible for repairing and maintaining the extracellular matrix that strengthens skin. Collagen, elastin, and other skin proteins can be found in the extracellular matrix in the skin. Research studies in rats have suggested that Epithalon may activate fibroblasts to the extent of up to 30-45%, though these studies continue to be conducted.

Epithalon is considered a unique molecule, particularly when exposed to the skin surface, as the peptide may potentially penetrate the skin barrier to ender cells and stimulate the growth and development of fibroblasts, which secrete impactful proteins like collagen. This may produce a significantly potent impact, leading to skin cell regeneration at multiple levels, but this hypothesis requires further scientific investigation.

The epidermal layer becomes brittle over time, prone to lesions and small tears, and often subjected to chronic insults that lead to pressure ulcers, diabetic ulcers, and other afflictions. The potential of supporting epidermal structure with increased protein production may contribute to the strength and efficacy of the skin barrier, and potentially mitigate instances of damage, disease, or infection.

NOTE: These products are intended for laboratory research use only. This peptide is not intended for personal use. Please review and adhere to our Terms and Conditions before ordering.

Dr. Marinov

Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research.

Latest Blog Articles

Thymogen Potential in Immune Cell Regulation

CJC-1295 & Hexarelin Blend Potential for Growth Hormone Signaling Stimulation

Oxytocin Actions On Neuronal Circuits in Different Mammalian Research Models

Kisspeptin 45-54 Peptide Interactions with Hypothalamic and Neuronal Cells

T-31 Peptide Interactions with Cellular Aging, Renewal, and Stress Pathways

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Key takeaways

Peptides Offer Targeted Relief: Core peptides interact with specific receptors and pathways in the gut, offering more precise mechanisms to address IBS symptoms compared to broader, systemic drugs.
Diverse Mechanisms of Action: Different peptides are being researched for IBS-C and IBS-D, with some promoting fluid secretion and gut motility for constipation, and others reducing inflammation and hypersensitivity for diarrhea.
Emerging Clinical Evidence: While still in various stages of research, several peptides have already gained FDA approval for IBS-C, demonstrating the clinical viability and efficacy of peptide-based therapies.
Importance of Responsible Research: Due to the complexity and emerging nature of peptide science, it is crucial for researchers and individuals to source high-quality, pure research peptides from reputable suppliers for accurate study.
Potential for Fewer Systemic Side Effects: Peptides often act locally within the gut, potentially leading to fewer systemic peptides side effects compared to other medications that affect the entire body.

puretestedpeptides.com

comparison

PSPeptides vs Core Peptides: A Direct Comparison

The most useful way to evaluate core peptides alternatives is a direct, factor-by-factor comparison. The table below shows how PSPeptides stacks up against Core Peptides across the criteria…

Source: pspeptides.com

Research context

Read sources and limitations before applying a claim.

Research

Researchers generally cease Hexarelin exposure within 2 weeks of initial introduction, as seen on average within the body of research on animal models. Doing otherwise was reported in some studies to potentially lead to an insignificant rise in growth hormone production due to, potentially, an increase in desensitization. A study opposing this practice was conducted. The experiment was performed on animal research subjects to examine Hexarelin’s desensitization rate in daily exposure. The subjects’ blood was drawn four times over 16 weeks and analyzed. Upon evaluation, the researchers concluded that Hexarelin appeared to have presented an insignificant difference in desensitization after the first and fourth week of exposure. Animal subjects exposed to Hexarelin reportedly presented muscle size increases, likely resulting from new myocytogenesis. Hexarelin also displayed accelerated injury recovery and, in some cases, was observed to have benefited cardiac functioning. Animal subjects without the ability to generate their own hGH naturally, were observed over the course of the study. The peptide has also been researched for its potential to increase epidermal elasticity, and has been suggested by researchers to exhibit properties that encompass possible injury prevention through increased epidermal structure and strength, and hastened recovery in damaged tissue. Hexarelin has been suggested to provide a variety of properties, with its most prominent potential actions speculated within the realm of fat regulation, cardiac protection, and muscle mass preservation. Initial research supports Hexarelin’s potential as a CD36 agonist, a protein involved in lipolysis control, and management of fatty acid breakdown. Exposure of cultured murine adipose to Hexarelin reportedly resulted in CD36 activation, which scientists reported drew out the reduced expression of PEPCK.(2) Since PEPCK is linked to the breakdown of fatty acids, this implies that this process may be regulated by CD36, and may potentially be thus activated by this peptide. Abnormal amounts of fat in the blood are referred to as dyslipidemia. Rodent research suggests that growth hormone-releasing peptide 6 (GHRP-6) may potentially inhibit dyslipidemia in an insulin resistance setting while lowering blood sugar and insulin resistance. Hexarelin may potentially provide an alternative to the lipid compounds currently widespread in research studies within the context of severe dyslipidemia.

Source: corepeptides.com ↗

Oxytocin Actions On Neuronal Circuits in Different Mammalian Research Models

Jun 30, 2026 Oxytocin is posited to be a cyclic nonapeptide composed of nine amino acids in the sequence Cys–Tyr–Ile–Gln–Asn–Cys–Pro–Leu–Gly-NH2 (CYIQNCPLG-NH2), with a molecular weight of approximately 1007 Da....

Source: corepeptides.com ↗

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →